Siltuximab‐related favorable clinical outcome for a patient suffering from idiopathic multicentric Castleman disease
S Chrysochoou, A Kreft… - Case Reports in …, 2022 - Wiley Online Library
RationalCastleman disease is a rare lymphoproliferative disorder that can be subdivided
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease.
S Chrysochoou, A Kreft, E Schneider - Case Reports in Hematology, 2022 - europepmc.org
RationalCastleman disease is a rare lymphoproliferative disorder that can be subdivided
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease.
S Chrysochoou, A Kreft… - Case Reports in …, 2022 - search.ebscohost.com
RationalCastleman disease is a rare lymphoproliferative disorder that can be subdivided
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
[PDF][PDF] Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease
S Chrysochoou, A Kreft, E Schneider - 2022 - scienceopen.com
RationalCastleman disease is a rare lymphoproliferative disorder that can be subdivided
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease
S Chrysochoou, A Kreft… - Case Reports in …, 2022 - search.proquest.com
RationalCastleman disease is a rare lymphoproliferative disorder that can be subdivided
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
[HTML][HTML] Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease
S Chrysochoou, A Kreft, E Schneider - Case Reports in …, 2022 - ncbi.nlm.nih.gov
RationalCastleman disease is a rare lymphoproliferative disorder that can be subdivided
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease
S Chrysochoou, A Kreft… - Case reports in …, 2022 - pubmed.ncbi.nlm.nih.gov
RationalCastleman disease is a rare lymphoproliferative disorder that can be subdivided
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease.
S Chrysochoou, A Kreft, E Schneider - Case Reports in Hematology, 2022 - europepmc.org
RationalCastleman disease is a rare lymphoproliferative disorder that can be subdivided
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …
into unicentric and multicentric forms, the latter of which causes a spectrum of serious …